We are live on ! Find out more
Baillie Gifford & Co

Baillie Gifford & Co Portfolio holdings

AUM $110B
1-Year Est. Return 4.8%
 

Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.

This Fund
S&P 500
This Quarter Est. Return
+19.56%
1 Year Est. Return
+4.8%
3 Year Est. Return
+123.53%
5 Year Est. Return
+125.55%
10 Year Est. Return
+1,754.37%
AUM
$126B
AUM Growth
+$16.6B
Cap. Flow
-$1.76B
Cap. Flow %
-1.4%
Top 10 Hldgs %
40.55%
Holding
303
New
14
Increased
69
Reduced
196
Closed
15

Top Sells

Rank Stock Value
1
MELI icon
Mercado Libre
MELI
+$919M
2
TSLA icon
Tesla
TSLA
+$857M
3
ILMN icon
Illumina
ILMN
+$616M
4
TTD icon
Trade Desk
TTD
+$273M
5
NFLX icon
Netflix
NFLX
+$211M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 29.23%
2 Technology 27.33%
3 Healthcare 14.71%
4 Communication Services 12.31%
5 Financials 6.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
76
Thermo Fisher Scientific
TMO
$220B
$356M 0.28%
671,165
-25,769
-4% -$12.5M
XYL icon
77
Xylem
XYL
$28.1B
$351M 0.28%
3,066,639
+69,619
+2% +$6.95M
SITE icon
78
SiteOne Landscape Supply
SITE
$4.53B
$345M 0.27%
2,126,087
-93,623
-4% -$13.6M
PINS icon
79
Pinterest
PINS
$13.4B
$345M 0.27%
9,305,759
+1,043,173
+13% +$32.8M
ALB icon
80
Albemarle
ALB
$15.5B
$340M 0.27%
2,355,871
-83,301
-3% -$11.4M
ADSK icon
81
Autodesk
ADSK
$52.6B
$322M 0.26%
1,322,121
+429,071
+48% +$92.7M
BIDU icon
82
Baidu
BIDU
$37.2B
$312M 0.25%
2,618,533
-15,317
-0.6% -$1.77M
DNLI icon
83
Denali Therapeutics
DNLI
$3.97B
$306M 0.24%
14,260,724
-420,303
-3% -$8.32M
TXN icon
84
Texas Instruments
TXN
$261B
$306M 0.24%
1,795,191
+1,385,725
+338% +$215M
TWLO icon
85
Twilio
TWLO
$36.6B
$293M 0.23%
3,863,887
-218,734
-5% -$13.6M
ROKU icon
86
Roku
ROKU
$22.7B
$282M 0.22%
3,074,831
-124,821
-4% -$10.4M
EXAS
87
DELISTED
Exact Sciences
EXAS
$279M 0.22%
3,767,055
-299,275
-7% -$19.6M
ADBE icon
88
Adobe
ADBE
$105B
$265M 0.21%
443,966
-323,021
-42% -$186M
PODD icon
89
Insulet
PODD
$9.79B
$263M 0.21%
+1,212,759
New +$208M
FND icon
90
Floor & Decor
FND
$6.68B
$262M 0.21%
2,345,761
-126,040
-5% -$11.6M
ODD icon
91
ODDITY Tech
ODD
$651M
$255M 0.2%
5,479,087
-80,730
-1% -$2.73M
SPT icon
92
Sprout Social
SPT
$621M
$253M 0.2%
4,114,040
-290,362
-7% -$15.3M
INSP icon
93
Inspire Medical Systems
INSP
$1.74B
$250M 0.2%
1,229,879
+1,212,175
+6,847% +$196M
EL icon
94
Estee Lauder
EL
$32B
$248M 0.2%
1,694,595
-72,962
-4% -$9.68M
ECL icon
95
Ecolab
ECL
$79.9B
$243M 0.19%
1,225,068
+51,709
+4% +$9.3M
TME icon
96
Tencent Music
TME
$15.6B
$241M 0.19%
26,745,199
-849,764
-3% -$6.58M
POOL icon
97
Pool Corp
POOL
$7.5B
$240M 0.19%
603,185
-29,540
-5% -$10.4M
RXRX icon
98
Recursion Pharmaceuticals
RXRX
$1.73B
$238M 0.19%
24,179,504
-371,905
-2% -$2.65M
FIX icon
99
Comfort Systems
FIX
$59.6B
$236M 0.19%
1,146,299
-41,621
-4% -$7.69M
RELY icon
100
Remitly
RELY
$5.14B
$216M 0.17%
11,131,233
+5,057,557
+83% +$113M

Similar funds

Baillie Gifford & Co's Q4 2023 Portfolio in Review

As of Q4 2023, Baillie Gifford & Co held 303 positions worth $126B, up 15% from $110B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Baillie Gifford & Co's Q4 2023 filing shows 14 new, 69 increased, 196 reduced and 15 closed positions. Its largest new stake was Insulet: 1,212,759 shares worth $263M. The largest sale was Mercado Libre, an estimated $919M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 29% of assets, down from 30% a quarter earlier, followed by Technology and Healthcare.

  • Baillie Gifford & Co's largest Q4 2023 buy was Insulet: 1,212,759 shares worth $263M.
  • Baillie Gifford & Co added most to Enphase Energy in Q4 2023, an estimated $433M increase.
  • Baillie Gifford & Co's biggest Q4 2023 reduction was Mercado Libre, cutting an estimated $919M.
  • Baillie Gifford & Co fully exited Abcam PLC in Q4 2023, selling an estimated $165M.
  • Baillie Gifford & Co's ten largest holdings make up 41% of its $126B portfolio in Q4 2023.
  • Baillie Gifford & Co opened 14 new positions and closed 15 in Q4 2023.
  • Baillie Gifford & Co's portfolio value rose 15% quarter-over-quarter to $126B.

Based on Baillie Gifford & Co's 13F filing for Q4 2023, filed 26 Jan 2024.